Insider · CIK 0001763581

Schoenberg Mark

Reports to the SEC for 1 company · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001763581

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-08	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−871 sh	$42.92	−$37.4K	59,882
2026-09-07	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,667 sh	—	—	60,753
2026-09-07	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,667 sh	—	—	0
2026-08-20	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−60.7K sh	$47.05	−$2.85M	59,086
2026-07-09	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−10K sh	$40.00	−$400K	119,763
2026-06-22	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−10K sh	$35.01	−$350K	129,763
2026-06-08	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	—	—	144,985
2026-06-08	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−5,222 sh	$27.30	−$143K	139,763
2026-06-08	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	0
2026-05-08	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−10K sh	$30.00	−$300K	134,985
2026-02-03	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−1,844 sh	$19.69	−$36.3K	150,514
2026-02-03	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−1,843 sh	$19.69	−$36.3K	148,671
2026-02-03	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−3,686 sh	$19.69	−$72.6K	144,985
2026-01-31	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,333 sh	—	—	145,692
2026-01-31	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,666 sh	—	—	152,358
2026-01-31	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,334 sh	—	—	142,359
2026-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,333 sh	—	—	3,334
2026-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,666 sh	—	—	13,334
2026-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,334 sh	—	—	0
2026-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+20K sh	—	—	20,000
2025-11-19	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−10K sh	$25.00	−$250K	139,025
2025-09-08	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−871 sh	$19.11	−$16.6K	149,025
2025-09-07	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,667 sh	—	—	149,896
2025-09-07	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,667 sh	—	—	1,667
2025-08-11	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−10K sh	$17.69	−$177K	148,229
2025-07-28	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	—	—	163,378
2025-07-28	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−5,149 sh	$19.14	−$98.6K	158,229
2025-06-09	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−5,162 sh	$7.37	−$38K	153,378
2025-06-08	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	—	—	158,540
2025-06-08	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	10,000
2025-01-31	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,334 sh	—	—	146,425
2025-01-31	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−759 sh	$11.14	−$8,455.26	145,666
2025-01-31	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,333 sh	—	—	148,999
2025-01-31	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−1,896 sh	$11.14	−$21.1K	147,103
2025-01-31	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,333 sh	—	—	150,436
2025-01-31	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−1,896 sh	$11.14	−$21.1K	148,540
2025-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,334 sh	—	—	0
2025-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,333 sh	—	—	3,334
2025-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,333 sh	—	—	6,667
2025-01-31	URGNUroGen Pharma Ltd. · Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+20K sh	—	—	20,000
2024-09-09	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,666 sh	—	—	145,950
2024-09-09	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−859 sh	$13.08	−$11.2K	145,091
2024-09-09	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,666 sh	—	—	3,334
2024-06-10	URGNUroGen Pharma Ltd.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	—	—	149,437
2024-06-10	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−5,153 sh	$13.08	−$67.4K	144,284
2024-06-10	URGNUroGen Pharma Ltd. · Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	20,000
2024-03-18	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−12K sh	$14.05	−$169K	139,437
2024-02-01	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−1,137 sh	$15.78	−$17.9K	149,423
2024-02-01	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−758 sh	$15.78	−$12K	149,998
2024-02-01	URGNUroGen Pharma Ltd.S Sale	Chief Medical Officer	SSale	−1,894 sh	$15.78	−$29.9K	151,437

Recent filings

Accepted (ET)
Sep 94
Schoenberg Mark0001437749-26-029965
SEC(opens sec.gov)
Aug 244
Schoenberg Mark0001437749-26-028840
SEC(opens sec.gov)
Jul 104
Schoenberg Mark0001437749-26-023290
SEC(opens sec.gov)
Jun 244
Schoenberg Mark0001437749-26-021523
SEC(opens sec.gov)
Jun 94
Schoenberg Mark0001437749-26-019964
SEC(opens sec.gov)
May 114
Schoenberg Mark0001437749-26-016104
SEC(opens sec.gov)
Feb 44
Schoenberg Mark0001437749-26-003040
SEC(opens sec.gov)
Feb 34
Schoenberg Mark0001437749-26-002843
SEC(opens sec.gov)

Companies

UroGen Pharma Ltd.Chief Medical OfficerURGN

Address

400 ALEXANDER PARK DRIVE

PRINCETON, NJ, 08540